Better HIV Prevention for Cisgender Women
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women
This project aims to make it easier for cisgender women, especially Black women, to access and use effective ways to prevent HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11098733 on NIH RePORTER |
What this research studies
HIV disproportionately affects cisgender women, particularly Black women, often through heterosexual contact. We have effective tools like daily medication (PrEP) and condoms that can greatly reduce the risk of getting HIV. However, many women who could benefit from these prevention methods are not using them, sometimes because they don't think PrEP is for them or they are unaware of their partner's HIV status. Healthcare providers also face challenges in identifying women at high risk and discussing prevention options. This work seeks to understand and overcome these barriers so more women can protect themselves from HIV.
Who could benefit from this research
Good fit: This work is focused on cisgender women, particularly Black women, who are at risk for HIV infection.
Not a fit: Patients who are not cisgender women or are not at risk for HIV may not directly benefit from this specific prevention effort.
Why it matters
Potential benefit: If successful, this work could lead to more women using effective HIV prevention methods, significantly reducing new infections.
How similar studies have performed: While individual prevention methods like PrEP are proven effective, this work explores new ways to overcome barriers to their use among specific populations.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Coleman, Jenell S — Johns Hopkins University
- Study coordinator: Coleman, Jenell S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.